Featured posts

CTSW is pleased to have represented Ocuvex Therapeutics, Inc., a biopharmaceutical company specializing in ophthalmic therapeutics, in its Merger Agreement with Onconetix, Inc. (Nasdaq: ONCO). Under the Merger Agreement, Onconetix will acquire all Ocuvex equity interests in exchange for newly-issued Onconetix shares, resulting in Ocuvex equity holders owning 90% of the combined company, subject to […]

CTSW represented Aptitude 8, an Elite level HubSpot Global Partner, in its combination with OBO, establishing a premier HubSpot technical consulting firm. The transaction is the latest in the firm’s work with technology services clients in a M&A matters and a range of corporate transactions and agreements. Corporate attorneys Larry Tauber, Daniel Arbov, and Russ […]

CTSW represented Regor Pharmaceuticals in its sale of next-generation CDK inhibitors for breast cancer treatment to Genentech (a Roche Group member) for an upfront payment of $850 million plus milestone payments. CTSW advised on all aspects of the negotiation and transaction. We are proud to support impactful transactions driving pharmaceutical innovation.

CTSW represented a customer research technology firm in the sale of customer research technology to a life sciences commercialization company. The transaction is the latest in CTSW’s long history of work in M&A involving technology and life sciences. Robert Boghosian, Larry Tauber, and Monica Noguera worked on this transaction.

CTSW represented the sellers of an international business and enterprise technology consulting firm in a transaction with another large consulting firm. The transaction is the latest in CTSW’s M&A work with clients in technology services, solutions, and products. Larry Tauber, Russ Korins, and Monica Noguera worked on this transaction.

CTSW served as securities counsel to Forafric Agro Holdings Limited, a leading agribusiness company specializing in wheat processing, in connection with its business combination with Globis Acquisition Corp., a special purpose acquisition company. Forafric raised $45 million in new capital. The combined ordinary shares and public warrants of the combined company, which will do business […]